miR ‐203‐3p promotes senescence of mouse bone marrow mesenchymal stem cells via downregulation of Pbk
Aging Cell · 2024-11 · 23 (11)
DOI: 10.1111/acel.14293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, online erschienen am 09.08.2024. Verfasst von Qiaojuan Mei und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, MicroRNAs, Cellular Senescence, Down-Regulation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hubei Province technology innovation special major project, National Key Research and Development Program of China.
Abstract (Originalsprache)
The senescence of bone marrow mesenchymal stem cells (BMSCs) contributes to the development of degenerative skeletal conditions. To date, the molecular mechanism resulting in BMSC senescence has not been fully understood. In this study, we identified a small non‐coding RNA, miR‐203‐3p, the expression of which was elevated in BMSCs from aged mice. On the other hand, overexpression of miR‐203‐3p in BMSCs from young mice reduced cell growth and enhanced their senescence. Mechanistically, PDZ‐linked kinase (PBK) is predicted to be the target of miR‐203‐3p. The binding of miR‐203‐3p to Pbk mRNA could decrease its expression, which in turn inhibited the ubiquitination‐mediated degradation of p53. Furthermore, the intravitreal injection of miR‐203‐3p‐inhibitor into the bone marrow cavity of aged mice attenuated BMSC senescence and osteoporosis in aged mice. Collectively, these findings suggest that targeting miR‐203‐3p to delay BMSC senescence could be a potential therapeutic strategy to alleviate age‐related osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Gynecology, Maternal and Child Health Hospital of Hubei Province, Wuhan, China.
- The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Cardiology, Jinan Central Hospital, Shandong First Medical University, Jinan, Shandong, China.
- Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
ORCID-Profile: Wenpei Xiang
Förderung
- Hubei Province technology innovation special major project
- National Key Research and Development Program of China
Zitieren
APA
Mei, Q., Li, K., Tang, T., Cai, S., Liu, Y., Wang, X., Jia, Y., Zhang, L., Li, H., Song, H., Zhai, J., & Xiang, W. (2024). miR ‐203‐3p promotes senescence of mouse bone marrow mesenchymal stem cells via downregulation of Pbk. Aging Cell, 23(11). https://doi.org/10.1111/acel.14293
Vancouver
Mei Q, Li K, Tang T, Cai S, Liu Y, Wang X, et al. miR ‐203‐3p promotes senescence of mouse bone marrow mesenchymal stem cells via downregulation of Pbk. Aging Cell. 2024;23(11). doi:10.1111/acel.14293
BibTeX
@article{Mei2024,
author = {Mei, Qiaojuan and Li, Kexin and Tang, Tianyu and Cai, Siying and Liu, Yu and Wang, Xiaofei and Jia, Yinzhao and Zhang, Ling and Li, Huaibiao and Song, Hui and Zhai, Jun and Xiang, Wenpei},
title = {miR ‐203‐3p promotes senescence of mouse bone marrow mesenchymal stem cells via downregulation of Pbk},
journal = {Aging Cell},
year = {2024},
volume = {23},
number = {11},
doi = {10.1111/acel.14293}
}
EUVIMED